Radioactive labeling method for neuropeptide Y derivative compound and medicine for multi-type breast cancer therapy thereof
US11077217B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2018 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Dec 11, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/065
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a radioactive labeling method for neuropeptide Y (NPY) compound and a mammalian diagnostic radioactive targeting medicine with NPY peptide being modified at position 27th to 36th, and after binding with the chelating agent and labeling the radiation nucleus 66Ga67Ga68Ga177Lu or 111In to provide a radioactive targeting medicine for multi-type breast cancer diagnosis and treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.